Zobrazeno 1 - 10
of 201
pro vyhledávání: '"Robert B Jones"'
Autor:
Nikita Bhalerao, Asmi Chakraborty, Michael P. Marciel, Jihye Hwang, Colleen M. Britain, Austin D. Silva, Isam E. Eltoum, Robert B. Jones, Katie L. Alexander, Lesley E. Smythies, Phillip D. Smith, David K. Crossman, Michael R. Crowley, Boyoung Shin, Laurie E. Harrington, Zhaoqi Yan, Maigen M. Bethea, Chad S. Hunter, Christopher A. Klug, Donald J. Buchsbaum, Susan L. Bellis
Publikováno v:
JCI Insight, Vol 8, Iss 19 (2023)
The role of aberrant glycosylation in pancreatic ductal adenocarcinoma (PDAC) remains an under-investigated area of research. In this study, we determined that ST6 β-galactoside α2,6 sialyltransferase 1 (ST6GAL1), which adds α2,6-linked sialic aci
Externí odkaz:
https://doaj.org/article/8d74b6365a7e4f5aab8310300004ced9
Autor:
Kaitlyn A. Dorsett, Robert B. Jones, Katherine E. Ankenbauer, Anita B. Hjelmeland, Susan L. Bellis
Publikováno v:
Journal of Ovarian Research, Vol 12, Iss 1, Pp 1-13 (2019)
Abstract Background The ST6Gal-I glycosyltransferase, which adds α2–6-linked sialic acids to N-glycosylated proteins is upregulated in a wide range of malignancies including ovarian cancer. Prior studies have shown that ST6Gal-I-mediated sialylati
Externí odkaz:
https://doaj.org/article/b818a3a798914e8fa50cea2b13d78301
Autor:
Robert B. Jones, Jonathan Farhi, Miranda Adams, Kiran K. Parwani, Garrett W. Cooper, Milica Zecevic, Richard S. Lee, Andrew L. Hong, Jennifer M. Spangle
Publikováno v:
Cancer Research Communications. 2:1569-1578
The high frequency of aberrant PI3K pathway activation in hormone receptor–positive (HR+) breast cancer has led to the development, clinical testing, and approval of the p110α-selective PI3K inhibitor alpelisib. The limited clinical efficacy of al
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bf97f48a88a1382862148b4e2b7658a4
https://doi.org/10.1158/2767-9764.crc-22-0158
https://doi.org/10.1158/2767-9764.crc-22-0158
Autor:
Jennifer M. Spangle, Andrew L. Hong, Richard S. Lee, Milica Zecevic, Garrett W. Cooper, Kiran K. Parwani, Miranda Adams, Jonathan Farhi, Robert B. Jones
Figure S2 shows on-target activity of PI3K and MLL1 inhibitors
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0062b582ffb243aa55ff00c1636823df
https://doi.org/10.1158/2767-9764.22546227.v1
https://doi.org/10.1158/2767-9764.22546227.v1
Autor:
Jennifer M. Spangle, Andrew L. Hong, Richard S. Lee, Milica Zecevic, Garrett W. Cooper, Kiran K. Parwani, Miranda Adams, Jonathan Farhi, Robert B. Jones
Supplementary Table 1 shows p values for IHC staining that corresponds to the graphs shown in Figure 5D
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6537deacfa372c7347122a85bb9c6cb4
https://doi.org/10.1158/2767-9764.22546215
https://doi.org/10.1158/2767-9764.22546215
Autor:
Jennifer M. Spangle, Andrew L. Hong, Richard S. Lee, Milica Zecevic, Garrett W. Cooper, Kiran K. Parwani, Miranda Adams, Jonathan Farhi, Robert B. Jones
The high frequency of aberrant PI3K pathway activation in hormone receptor–positive (HR+) breast cancer has led to the development, clinical testing, and approval of the p110α-selective PI3K inhibitor alpelisib. The limited clinical efficacy of al
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c6fcce0da8f88e1b840396b92b49da3
https://doi.org/10.1158/2767-9764.c.6551121.v1
https://doi.org/10.1158/2767-9764.c.6551121.v1
Autor:
Michael Li, Dina S. Zaret, Christa M. Smaltz, Chantel M. Venkataraman, David B. Ney, Divya M. Chalikonda, Chris J. Li, Joshua D. Mairose, Dianna R. Cheney-Peters, Margaret V. Szot, Rukaiya Bashir-Hamidu, Joseph W. Schaefer, Kashyap Chauhan, Alan A. Kubey, M.P.H. Crystal Y. Lee, Conor G. Bradley, Joshua M. Riley, Danielle M. Fitzpatrick, Robert B. Jones, Shuji Mitsuhashi
Publikováno v:
Journal of Medical Virology. 94:1550-1557
BACKGROUND International Statistical Classification of Disease and Related Health Problems, 10th Revision codes (ICD-10) are used to characterize cohort comorbidities. Recent literature does not demonstrate standardized extraction methods. OBJECTIVE
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b302153a5e5d2592039096b1440c65dc
https://doi.org/10.1002/jmv.27492
https://doi.org/10.1002/jmv.27492
Autor:
Shuji Mitsuhashi, M.P.H. Crystal Y. Lee, Joshua D. Mairose, Dina S. Zaret, Joshua M. Riley, Robert B. Jones, Divya M. Chalikonda, David B. Ney, Chantel M. Venkataraman, Danielle M. Fitzpatrick, Dianna R. Cheney-Peters, Joseph W. Schaefer, Rukaiya Bashir-Hamidu, Kashyap Chauhan, Alan A. Kubey, Brandon George, Margaret V. Szot, Christa M. Smaltz, Conor G. Bradley, Chris J. Li
Publikováno v:
Journal of Medical Virology
Objective COVID-19 has disproportionately affected low-income communities and people of color. Previous studies demonstrated that race/ethnicity and socioeconomic status (SES) are not independently correlated with COVID-19 mortality. The purpose of o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ca5b7b5bef894dc9b36d4d0fca5dd500
https://doi.org/10.1002/jmv.27365
https://doi.org/10.1002/jmv.27365
Autor:
Jonathan Farhi, Robert B. Jones, Ashish K. Verma, Kiran K. Parwani, Kuei-Chien Tang, Benjamin Emenike, Pritha Bagchi, Monika Raj, Jennifer M. Spangle
Dynamic protein post-translation methylation is essential for cellular function, highlighted by the essential role of methylation in transcriptional regulation and its aberrant dysregulation in diseases including cancer. This underscores the importan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7738c532e74f6c6748b283fe8766f644
https://doi.org/10.1101/2022.07.22.501130
https://doi.org/10.1101/2022.07.22.501130
Autor:
Asmi Chakraborty, Nikita Bhalerao, Michael P. Marciel, Jihye Hwang, Colleen M. Britain, Isam E. Eltoum, Robert B. Jones, Katie L. Alexander, Lesley E. Smythies, Phillip D. Smith, David K. Crossman, Michael R. Crowley, Boyoung Shin, Laurie E. Harrington, Zhaoqi Yan, Maigen M. Bethea, Chad S. Hunter, Christopher A. Klug, Donald J. Buchsbaum, Susan L. Bellis
The role of aberrant glycosylation in pancreatic ductal adenocarcinoma (PDAC) remains an under-investigated area of research. In this study, we determined that the ST6GAL1 sialyltransferase, which adds α2,6-linked sialic acids to N-glycosylated prot
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::11ae38bdc7e94e2badb9663c43f4f37b
https://doi.org/10.1101/2022.04.28.489561
https://doi.org/10.1101/2022.04.28.489561